FENNEC PHARMACEUTICALS INC. Earnings Per Share (Basic)
FENNEC PHARMACEUTICALS INC. (FENC) reported Earnings Per Share (Basic) of $0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.06.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2026-03-31 was $0.01.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.02.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.11.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for fiscal 2025 was -$0.34.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for fiscal 2024 was -$0.02.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for fiscal 2023 was -$0.60.
- FENNEC PHARMACEUTICALS INC. earnings per share, basic for fiscal 2022 was -$0.90.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.06 10-Q · filed 2026-08-13 | $0.06 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | $0.01 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | -$0.34 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | -$0.02 10-Q · filed 2025-11-13 | -$0.18 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$0.11 10-Q · filed 2026-08-13 | -$0.16 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$0.04 10-Q · filed 2026-05-14 | |||||||
| 2024-12-31 | -$0.02 10-K · filed 2026-03-27 | |||||||
| 2024-09-30 | -$0.21 10-Q · filed 2025-11-13 | $0.06 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | -$0.20 10-Q · filed 2025-08-14 | $0.24 10-Q · filed 2025-08-14 | $0.27 10-Q · filed 2024-08-13 | |||||
| 2024-03-31 | $0.47 10-Q · filed 2025-05-14 | $0.41 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | -$0.60 10-K · filed 2025-03-26 | |||||||
| 2023-09-30 | -$0.07 10-Q · filed 2024-11-08 | -$0.50 10-Q · filed 2024-11-08 | ||||||
| 2023-06-30 | -$0.21 10-Q · filed 2024-08-13 | -$0.43 10-Q · filed 2024-08-13 | ||||||
| 2023-03-31 | -$0.23 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | -$0.90 10-K · filed 2024-03-29 | |||||||
| 2022-09-30 | -$0.31 10-Q · filed 2023-11-09 | -$0.65 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | -$0.19 10-Q · filed 2023-08-07 | -$0.34 10-Q · filed 2023-08-07 | ||||||
| 2022-03-31 | -$0.14 10-Q · filed 2023-05-12 | |||||||
| 2021-12-31 | -$0.67 10-K · filed 2023-03-29 | |||||||
| 2021-09-30 | -$0.16 10-Q · filed 2022-11-14 | -$0.50 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.15 10-Q · filed 2022-08-12 | -$0.34 10-Q · filed 2022-08-12 | ||||||
| 2021-03-31 | -$0.18 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | -$0.76 10-K · filed 2022-02-28 | |||||||
| 2020-09-30 | -$0.24 10-Q · filed 2021-11-10 | -$0.64 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$0.21 10-Q · filed 2021-08-10 | -$0.40 10-Q · filed 2021-08-10 | ||||||
| 2020-03-31 | -$0.19 10-Q · filed 2021-05-13 | $0.19 10-Q · filed 2020-05-14 | ||||||
| 2019-09-30 | -$0.09 10-Q · filed 2020-11-16 | -$0.46 10-Q · filed 2020-11-16 | ||||||
| 2019-06-30 | -$0.24 10-Q · filed 2020-08-05 | -$0.37 10-Q · filed 2020-08-05 | ||||||
| 2019-03-31 | $0.14 10-Q · filed 2020-05-14 | -$0.13 10-Q · filed 2019-05-10 | ||||||
| 2018-09-30 | -$0.14 10-Q · filed 2019-11-12 | -$0.37 10-Q · filed 2019-11-12 | ||||||
| 2018-06-30 | -$0.14 10-Q · filed 2019-08-09 | -$0.22 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | -$0.09 10-Q · filed 2019-05-10 | |||||||
| 2017-09-30 | -$0.15 10-Q · filed 2018-11-13 | -$0.32 10-Q · filed 2018-11-13 | $0.32 10-Q · filed 2017-11-13 | |||||
| 2017-06-30 | -$0.11 10-Q · filed 2018-08-13 | -$0.17 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | -$0.06 10-Q · filed 2018-05-14 | |||||||
| 2016-09-30 | -$0.04 10-Q · filed 2017-11-13 | -$0.13 10-Q · filed 2017-11-13 | ||||||
| 2016-06-30 | -$0.06 10-Q · filed 2017-08-14 | -$0.10 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | -$0.04 10-Q · filed 2017-05-12 | |||||||
| 2015-12-31 | -$0.06 10-K · filed 2016-03-28 | |||||||
| 2015-09-30 | -$0.01 10-Q · filed 2016-11-14 | -$0.01 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | -$0.02 10-Q · filed 2016-08-12 | $0.00 10-Q · filed 2016-08-12 | ||||||
| 2015-03-31 | $0.02 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | -$0.22 10-K · filed 2016-03-28 | |||||||
| 2014-09-30 | $0.04 10-Q · filed 2015-11-12 | -$0.36 10-Q · filed 2015-11-12 | ||||||
| 2014-06-30 | -$0.08 10-Q · filed 2015-08-11 | -$0.40 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | -$0.33 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | $0.19 10-K · filed 2015-03-31 | $0.06 10-K · filed 2014-03-31 | ||||||
| 2012-12-31 | -$0.21 10-K · filed 2014-03-31 | |||||||
| 2012-03-31 | $0.11 10-Q · filed 2012-05-15 | |||||||
| 2011-12-31 | $0.20 10-K · filed 2013-04-01 | |||||||
| 2011-03-31 | $0.23 10-Q · filed 2012-05-15 | |||||||
| 2010-12-31 | -$0.49 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |